A long-term multicentre assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis
- 1 September 1996
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 135 (3) , 385-389
- https://doi.org/10.1046/j.1365-2133.1996.d01-1009.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Topically applied low-dose calcitriol has no calciotropic effect in patients with stable plaque psoriasisJournal of the American Academy of Dermatology, 1994
- Calcitriol (1α,25-Dihydroxyvitamin D3) Ointment in Psoriasis, a Safety Tolerance and Efficacy Multicentre StudyDermatology, 1994
- Topical treatment of psoriatic plaques with 1,25-dihydroxyvitamin D3: a cell biological studyBritish Journal of Dermatology, 1993
- Topical application of 1,25-dihydroxyvitamin D3 (calcitriol) is an effective and reliable therapy to cure skin lesions in psoriatic childrenEuropean Journal of Pediatrics, 1993
- Topical calcitriol in the treatment of chronic plaque psoriasis: a double-blind studyBritish Journal of Dermatology, 1993
- 1α, 25-Dihydroxyvitamin D3 (calcitriol) ointment in psoriasisJournal of Dermatological Treatment, 1992
- A novel approach for the evaluation and treatment of psoriasis: Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasisJournal of the American Academy of Dermatology, 1988
- 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells.Journal of Clinical Investigation, 1984
- Reproducibility of Clinical Trials of Topical GlucocorticosteroidsInternational Journal of Dermatology, 1983
- Evaluation of PUVA, topical corticosteroids and the combination of both in the treatment of psoriasisBritish Journal of Dermatology, 1978